The Janus face of Bifidobacterium in the development of atopic eczema: A role for compositional maturation Depner M, Ege MJ, Hazard Taft D, Peschel S, Roduit C, Karvonen AM, Barnig C, Divaret-Chauveau A,Riedler J, Pekkanen J, Schmausser-Hechfellner E, Lauener R, Roponen M, Renz H, Pfefferle PI, Schaub B, von Mutius E, Kirjavainen PV and the PASTURE study group Pediatr Allergy Immunol. 2025 Feb; 36(2):e70041, 2025 DOI: 10.1111/pai.70041 PMID: 39932047
Low type-2 immune effectros modulate atopic diseases’ protective role in pancreatic cancer risk He J, Alhamwe BA, Sabroso S, Carrato A, Hidalgo M, Molero X, Iglesias M, Perea J, Farre A, Tardon A, Dominuez-Munoz E, Barbera V, Munoz-Bellvis L, Löhr M, Greenhalf W, O’Rorke M, Gress T, Crnogorac-Jurcevic T, Gaya A, Langtry A, Kleeff J, Lawlor R, Real FX, Renz H, Malats N Int. J. Cancer. 2025; 157:468-479 DOI: 10.1002/ijc.35397 PMID: 40098454
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs Gremke N, Besong I, Stroh A, von Wichert L, Witt M, Elmshäuser S, Wanzel M, Fromm MF, Taudte RV, Schmatloch S, Karn T, Reinisch M, Hirmas N, Loibl S, Wündisch T, Litmeyer AS, Jank P, Denkert C, Griewing S,Wagner U, Stiewe T Signal Transduction and Targeted Therapy, 10, 92; 2025 DOI: 10.1038/s41392-025-02180-4 PMID: 40113784
Infections in immunocompromised hosts: progress made and challenges ahead Sassine J, Skevaki C, Chemaly RF; European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV) Clinical Microbiology and Infection 31(1):22-23 DOI: 10.1016/j.cmi.2024.10.017 PMID: 39447745
Effects of long-term corticosteroid use on susceptibility to respiratory viruses: a narrative review Fragkou PC, Dimopoulou D, Moschopoulos CD, Skevaki C; ESCMID Study Group for Respiratory Viruses (ESGREV) Clinical Microbiology and Infection 31(1):43-48 DOI: 10.1016/j.cmi.2024.09.014 PMID: 39332599
The Care Continuum of Patients With Influenza in the Post–COVID-19 Era: A Position Paper Karakonstantis S, Lytras T, Keske S, Tsiodras S, Papst L, Ioannou P, Velikov P, Berg LP, De Angelis G, Prendki V, Adlhoch C, Penttinen P, Rello J, Gavazzi G, Malhotra-Kumar S, Skevaki C, Slafkosky M, Rath B. Journal of Infectious Diseases 232:333-346 DOI: 10.1093/infdis/jiaf333 PMID: 41102611
Roads to remission: evolving treatment concepts in type 2 inflammatory diseases Lommatzsch M, Blumchen K, Beck LA, Bousquet J, Brusselle GG, Fokkens WJ, Hamelmann E, Lau S, Ott H, Pfarr O, Sampson HA, Smolen JS, Taube C, Tarner ICH, Wagemann M, Werfel T, Worm M, Renz H EClinicalMedicine 8;80:103050 DOI: 10.1016/j.eclinm.2024.103050 PMID: 39867971
Wege zur Remission: Neue Behandlungskonzepte bei entzündlichen Typ-2-Erkrankungen Lommatzsch M, Blumchen K, Beck LA, Bousquet J, Brusselle GG, Fokkens WJ, Hamelmann E, Lau S, Ott H, Pfarr O, Sampson HA, Smolen JS, Taube C, Tarner ICH, Wagemann M, Werfel T, Worm M, Renz H Allergologie, Jahrgang 48, Nr. 12/2025, S.678-679
Impact of Residential Greeness Exposure on the Development of Allergic Diseases and Asthma and on Asthma Control – A Systematic Review for the EAACI Guidelines of Environmental Science for Allergic Diseases and Asthma Agache I, Balbin-Ramon GJ, Fernandez Saenz FK, Sola-Arnau I, Alonso-Coello P, Haahtela T, Traidl-Hoffmann C, O’Mahony L, Damialis A, Lauerma A, Nadeau KC, Pali-Schöll I, Palomares O, Renz H, Schwarze J, Vercelli D, Canelo-Aybar C, Jutel M, Akdis CA Allergy, 2025; 0:1-16 DOI: 10.1111/all.16653 PMID: 40632014